8.1 Breast-Conserving Surgery, Margin Standards & Mastectomy Techniques

Principles of Breast-Conserving Surgery (BCS)

Breast-conserving surgery (BCS)—variously termed lumpectomy, wide local excision, or partial mastectomy—aims to resect the primary breast malignancy with an adequate rim of normal surrounding parenchyma while preserving the natural cosmetic contour of the breast. Landmark randomized clinical trials with long-term follow-up exceeding 20 years, including the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-06 trial and the Milan I trial directed by Umberto Veronesi, definitively established that BCS followed by whole-breast radiation therapy (WBRT) yields equivalent overall survival (OS) and disease-free survival (DFS) compared to total mastectomy for stage I and stage II invasive breast carcinomas.

Absolute Contraindications to Breast-Conserving Surgery

Patient selection for BCS requires rigorous multidisciplinary evaluation. When specific clinical, radiologic, or pathological barriers prevent either complete oncologic clearance or safe delivery of adjuvant radiotherapy, mastectomy remains mandatory. Using the NCCN framework, absolute contraindications include:

1. Widespread Disease That Cannot Be Excised With Negative Margins and Acceptable Cosmesis: Extensive or multicentric disease that local excision cannot clear with a satisfactory cosmetic result. Clinical distinction: Multicentric disease involves separate quadrants, whereas multifocal disease refers to multiple tumors within one quadrant. Multicentricity alone is no longer an automatic contraindication: the ACOSOG Z11102 (Alliance) trial reported a 5-year local recurrence rate of about 3% when women with two or three ipsilateral foci had lumpectomy with negative margins plus whole-breast radiation, so breast conservation can be offered to selected patients with two or three foci.
2. Diffuse, Widespread Malignant-Appearing Microcalcifications: Extensive, branching, pleomorphic, or indeterminate calcifications scattered across multiple quadrants on mammography that preclude achieving complete microscopic clearance without total mastectomy.
3. Diffusely Positive Pathologic Margins: Positive margins that persist after reasonable re-excision attempts, so clearance is impossible without mastectomy.
4. Radiation That Would Have to Be Given During Pregnancy: Radiation therapy is contraindicated during gestation because of fetal risk. Breast-conserving surgery is still possible during pregnancy (especially in the second and third trimesters) when radiation can be deferred until after delivery, often because chemotherapy is given in between; a first-trimester diagnosis more often leads to mastectomy.
5. Biallelic (Homozygous) ATM Mutation: Patients with ataxia-telangiectasia are extremely radiosensitive, so radiation-based breast conservation is avoided.

Relative Contraindications to Breast-Conserving Surgery

Relative contraindications warrant individualized multidisciplinary risk stratification:

1. Active Connective Tissue / Collagen Vascular Diseases: Active systemic lupus erythematosus (SLE) and systemic sclerosis (scleroderma) are associated with severe microvascular hypersensitivity to therapeutic radiation, resulting in extensive cutaneous ulceration, ischemic chest wall necrosis, and intractable myositis. Rheumatoid arthritis and Hashimoto thyroiditis are not absolute contraindications.
2. Unfavorable Tumor-to-Breast Size Ratio: A large primary tumor (e.g. 4 to 5 cm) situated within a small, compact breast. Although technically resectable, standard lumpectomy would result in severe parenchymal volume loss and unacceptable cosmetic asymmetry unless volume replacement oncoplastic surgery or neoadjuvant systemic therapy is employed to downstage the primary tumor prior to surgical resection.
3. Deleterious Germline Pathogenic Variants (BRCA1, BRCA2, TP53): Patients harboring high-penetrance genetic mutations have identical locoregional control of the index lesion with BCS plus radiation compared to non-carriers. However, their extraordinarily high lifetime risk of secondary ipsilateral breast events (1-2% per year) and contralateral breast cancer (30-50% cumulative lifetime risk) frequently leads to the clinical selection of bilateral risk-reducing mastectomy.
4. Prior Radiation to the Breast or Chest Wall: Mantle radiation for Hodgkin lymphoma or prior breast radiotherapy was once treated as an absolute barrier; NCCN now lists it as relative because repeat partial-breast irradiation can be considered when prior doses and volumes are known. Cumulative soft-tissue tolerance, fibrosis, and rib injury remain the concerns.
5. Tumor Larger Than 5 cm or Focally Positive Margins: Handled case by case, often with neoadjuvant therapy or oncoplastic techniques.

Surgical Resection Margins Consensus Guidelines

Achieving pathologically clear resection margins during breast-conserving surgery is essential to reduce the risk of ipsilateral breast tumor recurrence (IBTR). Historical surgical practice was marked by wide discrepancies, with surgeons routinely performing extensive re-excisions for margins varying from 1 mm to 10 mm. Evidence-based multidisciplinary consensus panels have established standardized margin definitions that safely minimize unnecessary re-excisions.

SSO/ASTRO Consensus Guidelines for Invasive Breast Cancer

In 2014, the Society of Surgical Oncology (SSO) and the American Society for Radiation Oncology (ASTRO) published a joint consensus guideline on surgical margins for stage I and II invasive breast cancer treated with breast-conserving surgery and whole-breast radiation therapy:

• Consensus Standard: 'No ink on tumor' constitutes a negative surgical margin.
• Pathological Rationale: A negative margin is defined as the complete absence of ink touching malignant invasive tumor cells or associated ductal carcinoma in situ (DCIS) at the inked cut surface of the resected specimen. When whole-breast radiation therapy and systemic adjuvant therapies (endocrine therapy, chemotherapy, or HER2-targeted agents) are administered, obtaining wider surgical clearance (e.g. 1 mm, 2 mm, or 5 mm) does not lower the odds of IBTR compared to a simple margin where ink does not touch tumor cells.
• Avoidance of Routine Re-Excision: Re-excision is not routinely indicated for close but microscopically negative margins (e.g. 0.5 mm or 1 mm). Routine re-excision exposes patients to unnecessary surgical risks, general anesthesia, wound complications, psychological stress, delayed systemic treatment, and compromised aesthetic results.

SSO/ASTRO Consensus Guidelines for Ductal Carcinoma In Situ (DCIS)

In 2016, SSO and ASTRO established distinct margin criteria specifically for pure ductal carcinoma in situ (DCIS) treated with whole-breast radiation therapy:

• Consensus Standard: A 2 mm negative margin is the definitive minimum standard for DCIS.
• Pathological Rationale: Unlike invasive carcinoma, DCIS exhibits a propensity for discontinuous 'skip lesions' and branching arborization along the mammary ductal tree. Meta-analyses demonstrated that margins under 2 mm are associated with a statistically significant increase in 10-year ipsilateral recurrence rates, even when adjuvant whole-breast radiotherapy is delivered.
• Clinical Application: If DCIS is present less than 2 mm from the inked surgical margin, surgical re-excision is strongly recommended. However, margins wider than 2 mm (e.g. 5 mm or 10 mm) do not provide superior local control and are not recommended.
• Anatomical Boundaries Exception: If a surgical margin for either invasive cancer or DCIS is close (<2 mm) or even touching the deep pectoral fascia or superficial dermis, re-excision is not indicated provided that the surgeon has resected down to the deep investing pectoral muscle fascia or resected the overlying skin, because no further anatomical breast tissue remains to be excised in that directional vector.

Mastectomy Techniques and Postoperative Nursing Care

Mastectomy involves the surgical ablation of breast tissue and is tailored according to tumor extent, skin and nipple involvement, patient anatomy, and reconstructive intentions.

Spectrum of Mastectomy Procedures

1. Radical Mastectomy (Halsted Mastectomy): Developed by William Stewart Halsted in 1894, this historical procedure entailed the en bloc resection of the entire mammary gland, a wide ellipse of overlying skin, the nipple-areolar complex, both the pectoralis major and pectoralis minor muscles, and complete Levels I, II, and III axillary lymph nodes. While revolutionary in its era, it caused severe disfigurement, chest wall concavity, painful chronic arm lymphedema, and functional shoulder impairment. Large randomized trials confirmed that radical mastectomy provides no survival advantage over less disfiguring procedures. It is completely obsolete in modern breast surgical oncology, reserved solely for rare cases of direct malignant invasion into the pectoralis major and chest wall ribs.
2. Modified Radical Mastectomy (MRM): Entails the removal of the entire breast tissue, the nipple-areolar complex, a skin ellipse, and a formal Level I and Level II axillary lymph node dissection (ALND), while preserving both the pectoralis major and pectoralis minor muscles (the Auchincloss or Madden variations preserve both; the Patey modification divides or resects pectoralis minor for apical exposure). MRM was the historical standard of care throughout the late 20th century. Today, MRM is reserved for patients with biopsy-proven heavy axillary nodal involvement (e.g. inflammatory breast cancer or persistent gross matted nodes after neoadjuvant therapy) who are ineligible for sentinel node staging alone.
3. Total (Simple) Mastectomy: Resection of the entire breast parenchyma, nipple-areolar complex, and deep investing fascia of the pectoralis major muscle, without formal axillary dissection. A sentinel lymph node biopsy (SLNB) is routinely performed concurrently through the same incision or a separate axillary incision for staging. Total mastectomy is the standard procedure for extensive DCIS, early-stage invasive cancer with contraindications to BCS, prophylactic risk-reducing surgery, or local recurrence after prior BCS.
4. Skin-Sparing Mastectomy (SSM): Resection of the breast parenchyma, nipple-areolar complex, and previous percutaneous biopsy scars through a periareolar incision, while preserving the natural skin envelope and the inframammary fold (IMF). SSM facilitates immediate breast reconstruction (implant or autologous flap) by providing an anatomical skin pocket that matches native ptosis. Oncologic safety is equivalent to standard total mastectomy when margins are clear.
5. Nipple-Sparing Mastectomy (NSM): Preserves the entire cutaneous envelope including the nipple-areolar complex (NAC), utilizing an inframammary, lateral radial, or periareolar incision. Strict oncologic eligibility criteria include:
   • Primary tumor located >2 cm from the base of the nipple-areolar complex on pre-op imaging.
   • No clinical evidence of nipple retraction, Paget disease, or bloody nipple discharge.
   • Absence of inflammatory skin changes or tumor invasion into the dermis.
   • Retroareolar (sub-nipple) margin assessment: Tissue directly beneath the nipple is sent for frozen or permanent section. If invasive carcinoma or DCIS is found there, the nipple-areolar complex is excised (converting the operation to a skin-sparing mastectomy), either at once or as a second procedure.

Postoperative Nursing Management and Mobility Protocols

Care of the post-mastectomy patient centers on dead-space obliteration, surgical wound surveillance, seroma prevention, and structured rehabilitation of upper-extremity mobility.

Closed-Suction Drain (Jackson-Pratt [JP]) Care

Mastectomy and axillary surgery create extensive subcutaneous dead space beneath the elevated skin flaps. Closed-suction Jackson-Pratt (JP) drains prevent fluid accumulation (seroma/hematoma) and promote flap adherence to the chest wall:

• Milking / Stripping Tubing: Fibrinous clots and proteinaceous debris frequently occlude drain lumens. Nurses must teach patients to stabilize the tubing near the cutaneous insertion site with one hand to avoid traction pain, while using an alcohol swab or lotion-lubricated fingers of the other hand to firmly compress and slide distally toward the bulb reservoir, clearing intraluminal clots.
• Fluid Character Progression: Output typically progresses from bright red sanguinous drainage on postoperative day 1, transitioning to serosanguinous (pink/orange) over days 2 to 4, and finally to clear, straw-colored serous fluid. Sudden bright red output accompanied by a rapidly expanding, tense chest wall indicates postoperative hemorrhage/hematoma, requiring urgent surgical evaluation.
• Criteria for Drain Removal: Drains are maintained until 24-hour cumulative drainage decreases to <30 mL per 24 hours for 1 to 2 consecutive days (typically 7 to 14 days post-op). Premature removal dramatically increases seroma formation rates, whereas retaining drains beyond 2 to 3 weeks introduces retrograde bacterial colonization along the exit site, predisposing to surgical site infection.

Postoperative Range-of-Motion (ROM) Protocol

• Phase 1: Postoperative Days 1 to Drain Removal:
  • Encourage immediate gentle active movements of the distal ipsilateral extremity: ball squeezing, finger flexion/extension, wrist circles, and elbow flexion.
  • Encourage resumption of light activities of daily living: brushing teeth, eating, and gentle grooming.
  • Strict Movement Restriction: Shoulder abduction and forward flexion must be strictly restricted to ≤90 degrees (arm must not be raised above shoulder level). Vigorous shoulder elevation stretches the skin flaps across the chest wall, generates shear stress that disrupts capillary neovascularization, and mechanically stimulates excessive lymphatic drainage, prolonging drain dependence.
• Phase 2: Post-Drain Removal Rehabilitation:
  • Once closed-suction drains are discontinued and incisions are stable, active progressive shoulder range-of-motion exercises are initiated to prevent adhesive capsulitis ('frozen shoulder') and pectoral contractures.
  • Standard rehabilitation exercises: wall climbing (finger ladder crawl up a wall), wand/cane overhead flexion, shoulder rolls, and gentle doorway pectoral stretching, performed 3 to 4 times daily for 6 to 12 weeks.